A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into interactions ...
Optimizing gelatin hydrogels for volumetric 3D bioprinting. Insights from Rousselot’s Jos Olijve on the ENLIGHT bioprinting ...
Cell line-specific efficacy profiles: SIL204 showed robust activity across multiple pancreatic cancer cell ... In BxPC-3 (additional KRAS wild-type model): ~80% reduction in overall ...